PAM
CBPO

PSquared Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

PSquared Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-205,000
Closed -$24.2M – 11
2020
Q4 		$24.2M Buy
+205,000
New +$23.8M 3.85% 5

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PSquared Asset Management's CBPO Position: Q1 2021 in Review

PSquared Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 205,000 shares — an estimated $24.2M sold.

PSquared Asset Management first reported a position in CBPO in Q4 2020 and held it in 1 quarter. The position peaked at $24.2M in Q4 2020. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • PSquared Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • PSquared Asset Management sold 205,000 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $24.2M.
  • PSquared Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 1 quarter.
  • PSquared Asset Management's China Biologic Products Holdings, Inc. position peaked at $24.2M in Q4 2020.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on PSquared Asset Management's 13F filing for Q1 2021, filed 14 May 2021.